Locus Biosciences
PrivateLast Round
Grant
Jan 23, 2024
Total Funding Raised
$116.83M
Momentum Score
25 /100
Company Overview
Locus Biosciences is a biotechnology company that develops bacteriophage-based products aimed at precisely eliminating pathogenic bacteria from the human body through the innovative use of CRISPR-Cas3 technology and safe delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Locus Biosciences Comps
Public and private peers based on sector, stage, and business model.
Locus Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 23, 2024 | ||||
| Series B | May 18, 2022 | ||||
| Debt | Oct 19, 2021 | ||||
| Grant | Nov 10, 2020 | ||||
| Strategic | Jan 3, 2019 | ||||
Series A | Nov 14, 2017 |
Key People
Founding team and executive leadership
Locus Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| CARB-X | Grant |
| ARTIS Ventures | Series B, Series A |
| Abstract Ventures | Series A |
| Viking Global Investors | Series B |
| North Carolina Biotechnology Center | Series A, Debt, Convertible Debt |
| Johnson & Johnson Innovation - JLABS | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2025
Developing therapies for ophthalmic bacterial infections with Viatris.
- Oct 28, 2025
Partnering with Viatris Pharmaceuticals for ophthalmic therapies.
Locus Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Locus Biosciences's valuation, stock price, and market status.
